Log in

OTCMKTS:VYCOVycor Medical Stock Price, Forecast & News

$0.12
-0.07 (-36.00 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.12
Now: $0.12
$0.20
50-Day Range
$0.04
MA: $0.10
$0.14
52-Week Range
$0.01
Now: $0.12
$0.51
Volume55,906 shs
Average Volume23,637 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage that caused by a stroke. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive, computer-based rehabilitation targeted at an un-addressed market of people who have lost their sight as a result of stroke or other brain injury. It offers therapies that restore and compensate for lost vision, including VRT that delivers a series of light stimuli along the border of the patient's visual field loss; Neuro-Eye Therapy (NeET), which targets deep within the blind area by repeated stimulation, allowing patients to detect objects within the blind field; and NeuroEyeCoach, a complementary therapy to VRT and NeET. This segment also provides professional models of VRT and NeuroEyeCoach for physicians; and a clinic-based model comprising NeuroEyeCoach and VIDIT, a diagnostic program that enables therapists to perform high-resolution visual field tests in less than ten minutes. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:VYCO
CUSIP92921M203
Phone+1-562-5582000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive VYCO News and Ratings via Email

Sign-up to receive the latest news and ratings for VYCO and its competitors with MarketBeat's FREE daily newsletter.

Vycor Medical (OTCMKTS:VYCO) Frequently Asked Questions

How has Vycor Medical's stock been impacted by COVID-19 (Coronavirus)?

Vycor Medical's stock was trading at $0.0751 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VYCO stock has increased by 61.9% and is now trading at $0.1216. View which stocks have been most impacted by Coronavirus.

How were Vycor Medical's earnings last quarter?

Vycor Medical Inc (OTCMKTS:VYCO) issued its quarterly earnings data on Tuesday, May, 12th. The medical device company reported ($0.01) earnings per share for the quarter. The medical device company earned $0.35 million during the quarter. View Vycor Medical's earnings history.

Has Vycor Medical been receiving favorable news coverage?

Press coverage about VYCO stock has been trending negative recently, according to InfoTrie. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Vycor Medical earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned media stories about the medical device company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Vycor Medical.

Who are some of Vycor Medical's key competitors?

What other stocks do shareholders of Vycor Medical own?

Who are Vycor Medical's key executives?

Vycor Medical's management team includes the following people:
  • Mr. Adrian Christopher Liddell, Chairman, CFO & Director (Age 60)
  • Mr. Peter C. Zachariou, Chief Exec. Officer and Director (Age 57)
  • Mr. David Marc Cantor, Pres & Director (Age 53)

What is Vycor Medical's stock symbol?

Vycor Medical trades on the OTCMKTS under the ticker symbol "VYCO."

How do I buy shares of Vycor Medical?

Shares of VYCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vycor Medical's stock price today?

One share of VYCO stock can currently be purchased for approximately $0.12.

What is Vycor Medical's official website?

The official website for Vycor Medical is www.vycormedical.com.

How can I contact Vycor Medical?

Vycor Medical's mailing address is 951 Broken Sound Pkwy NW Ste 320, BOCA RATON, FL 33487-3531, United States. The medical device company can be reached via phone at +1-562-5582000.

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.